» Articles » PMID: 10812935

Improvement of Water Solubility and in Vitro Dissolution Rate of Gliclazide by Complexation with Beta-cyclodextrin

Overview
Journal Pharm Acta Helv
Specialty General Medicine
Date 2000 May 17
PMID 10812935
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Inclusion complexes of gliclazide with beta-cyclodextrin were prepared using different two methods: neutralization and recrysstalization. Host-guest interactions were studied in the solid state by X-ray diffractometry and infrared spectroscopy. The stability constant between gliclazide and beta-cyclodextrin was calculated from the phase solubility diagram. It was found that the neutralization technique and a solid complex of gliclazide with beta-cyclodextrin in a molar ratio of 1.5:1 could be used to prepare the amorphous state of drug inclusion complexes. The dissolution rates of gliclazide from the inclusion complex made by neutralization was much faster than the pure drug, physical mixture of drug and cyclodextrin, recyristalization system and also comparable to the data reported in literature. Results of this report indicate that beta-cyclodextrin could be useful for the solid gliclazide formulations as it may results in a more rapid and uniform release of the drug.

Citing Articles

Design, characterization, and evaluation of magnetic carboxymethylated β-cyclodextrin as a pH-sensitive carrier system for amantadine delivery: a novel approach for targeted drug delivery.

Hadadian M, Allahyari R, Mahdavi B, Rezaei-Seresht E RSC Adv. 2025; 15(1):446-459.

PMID: 39758925 PMC: 11698272. DOI: 10.1039/d4ra06269h.


Physicochemical reports of gliclazide-carplex solid dispersions and tablets prepared with directly compressible co-processed excipients.

Paul S, Asha K, Alam I, Ali M, Al-Mamun M, Rahman M Heliyon. 2023; 9(12):e22899.

PMID: 38076126 PMC: 10703618. DOI: 10.1016/j.heliyon.2023.e22899.


Development of a gliclazide ionic liquid and its mesoporous silica particles: an effective formulation strategy to improve oral absorption properties.

Zhou B, Teng D, Li J, Zhang Y, Qi M, Hong M RSC Adv. 2022; 12(2):1062-1076.

PMID: 35425111 PMC: 8978969. DOI: 10.1039/d1ra07499g.


Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles.

Nasr M, Almawash S, Al Saqr A, Bazeed A, Saber S, Elagamy H Pharmaceuticals (Basel). 2021; 14(8).

PMID: 34451883 PMC: 8398842. DOI: 10.3390/ph14080786.


Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model.

anic M, Stanimirov B, Pavlovic N, Vukmirovic S, Lazic J, Al-Salami H Front Pharmacol. 2019; 10:1083.

PMID: 31607925 PMC: 6771299. DOI: 10.3389/fphar.2019.01083.